Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Protectan CBLB-502 demonstrates effectiveness in ARS in primates

Aug. 2, 2006

Champix recommended for approval in Europe

July 31, 2006

Suboxone receives approval recommendation in Europe

July 31, 2006

Oral nalmefene demonstrates positive results in pilot smoking cessation study

July 28, 2006

European CHMP hands down positive opinion for Exjade

July 5, 2006

Valera seeks to begin clinical studies of VP-004 naltrexone implant

June 29, 2006

Pfizer patents novel nicotinic acetylcholine receptor modulators for promoting smoking cessation

June 29, 2006

Studies of NRP-104 pharmacokinetics, abuse potential reported

June 29, 2006

Preliminary results from phase II studies of cocaine vaccine TA-CD

June 28, 2006

Targeting the dopamine D3 receptor to block the reinforcing efficacy of nicotine

June 27, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 26, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026